F.D.A. Approves a New Antipsychotic Drug
Posted inBristol Myers Squibb Company Clinical Trials Dopamine Drugs (Pharmaceuticals) Food and Drug Administration Karuna Therapeutics Inc Psychiatry and Psychiatrists Psychology and Psychologists Regulation and Deregulation of Industry Research Schizophrenia Therapy and Rehabilitation Weight

F.D.A. Approves a New Antipsychotic Drug

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.
U.S. Unveils Price Limits for 10 Costly or Common Medications
Posted inAbbVie Inc Amgen Inc AstraZeneca PLC Biden, Joseph R Jr Boehringer Ingelheim GmbH Bristol Myers Squibb Company Drugs (Pharmaceuticals) Eli Lilly and Company Harris, Kamala D Inflation Reduction Act of 2022 Johnson & Johnson Medicare Merck & Company Inc Novartis AG Novo Nordisk A/S Pfizer Inc Presidential Election of 2024 Trump, Donald J United States Politics and Government

U.S. Unveils Price Limits for 10 Costly or Common Medications

The Biden administration said it would have saved $6 billion had the new prices been in effect last year.
U.S. to Announce Prices for First Drugs Picked for Medicare Negotiations
Posted inAbbVie Inc Amgen Inc AstraZeneca PLC Biden, Joseph R Jr Boehringer Ingelheim GmbH Bristol Myers Squibb Company Drugs (Pharmaceuticals) Eli Lilly and Company Harris, Kamala D Inflation Reduction Act of 2022 Johnson & Johnson Medicare Merck & Company Inc Novartis AG Novo Nordisk A/S Pfizer Inc Presidential Election of 2024 Trump, Donald J United States Politics and Government

U.S. to Announce Prices for First Drugs Picked for Medicare Negotiations

The Biden administration said it would have saved $6 billion had the new prices been in effect last year.
J&J, Merck and Bristol Myers Squibb CEOs Will Testify at Senate Hearing on Drug Prices
Posted inBristol Myers Squibb Company Drugs (Pharmaceuticals) Johnson & Johnson Merck & Company Inc Prices (Fares, Fees and Rates) Sanders, Bernard Senate Senate Committee on Health, Education, Labor and Pensions United States Politics and Government

J&J, Merck and Bristol Myers Squibb CEOs Will Testify at Senate Hearing on Drug Prices

The top executives of three major companies are set to appear on Thursday before a Senate panel led by Mr. Sanders, who has made lowering drug costs a signature issue.